Aug 13, 2026 07:34AM
Aug 13, 2026 07:30AM
Aug 10, 2026 07:30AM
May 14, 2026 07:52AM
May 14, 2026 07:30AM
May 14, 2026 07:30AM
May 14, 2026 07:30AM Karyopharm completes endometrial cancer trial enrollment, reports Q1 results
May 14, 2026 07:30AM
May 7, 2026 07:30AM
Feb 12, 2026 07:45AM
Feb 12, 2026 07:30AM
Feb 5, 2026 07:30AM
Nov 3, 2025 07:00AM
Oct 27, 2025 07:00AM Karyopharm to Report Third Quarter 2025 Financial Results on November 3, 2025
Oct 8, 2025 07:01AM
Oct 8, 2025 07:00AM
Aug 11, 2025 10:59AM
Aug 11, 2025 07:30AM
Aug 5, 2025 07:00AM
May 13, 2025 07:24AM
May 12, 2025 04:05PM Karyopharm Reports First Quarter 2025 Financial Results and Announces New Data in Myelofibrosis that Further Suggests Selinexor May Lead to Meaningful Spleen Volume Reduction, Symptom Improvement, Hem
May 8, 2025 04:05PM
Apr 12, 2025 04:00AM
Feb 19, 2025 07:33AM
Feb 19, 2025 07:30AM
Feb 12, 2025 07:00AM
Jan 15, 2025 06:42AM
Nov 5, 2024 07:34AM Karyopharm Therapeutics (KPTI) Reports In-Line Q3 EPS ; Offers Guidance
Nov 5, 2024 07:30AM
Oct 31, 2024 08:00AM
Aug 6, 2024 07:34AM
Aug 6, 2024 07:30AM
Jul 31, 2024 04:05PM
May 8, 2024 07:32AM
May 8, 2024 07:30AM Karyopharm Therapeutics (KPTI) Announces Significant Refinancing Transactions and Amended Royalty Agreement Extending Vast Majority of Its Debt Maturities into 2028 and 2029
May 8, 2024 07:30AM
May 8, 2024 07:30AM
May 2, 2024 04:30PM
Feb 29, 2024 07:32AM
Feb 29, 2024 07:30AM
Feb 22, 2024 07:00AM
Nov 2, 2023 07:34AM Karyopharm Therapeutics (KPTI) Misses Q3 EPS by 2c
Nov 2, 2023 07:30AM
Oct 26, 2023 07:00AM
Aug 2, 2023 07:33AM
Aug 2, 2023 07:30AM
Jul 26, 2023 07:00AM
May 4, 2023 08:21AM
May 4, 2023 07:45AM Karyopharm Reports First Quarter 2023 Financial Results and Highlights Recent Company Progress
May 1, 2023 04:05PM

1,223,532 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All